Verrica (VRCA) news
Recent news
Monkeypox stocks rose in regular trading, with TNXP up 6.8%, GILD gaining 2.5% and VTRS rising 1.9%.
On October 14, 2026, shares of companies associated with monkeypox treatments and vaccines rose in regular trading. Tonix Pharmaceuticals Holding Corp (TNXP) gained 6.8%, while Gilead Sciences (GILD) rose 2.5%, and Verrica Pharmaceuticals (VTRS) increased by 1.9%. The uptick in stock prices…
AInvest Wire · 1d agoVerrica Pharmaceuticals - Topline data from Cove-2 expected in Q1 2027
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported second-quarter 2026 financial results and business updates, highlighting continued growth in its flagship product, YCANTH, and progress in its clinical pipeline. The company noted that dispensed applicator units for YCANTH reached 19,626 in Q2…
AInvest Wire · Aug 27, 2026Verrica Pharmaceuticals shares rise 12% after partner reports trial results
AInvest Wire · Dec 15, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.